Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Utility of Pelvic MRV in Evaluation of Patients with Cryptogenic Stroke and PFO
Cerebrovascular Disease and Interventional Neurology
(-)
228
Authors/Disclosures
Marcey L. Osgood, DO
PRESENTER 		Dr. Osgood has nothing to disclose.
Elizabeth R. Budman, MD No disclosure on file
Nils Henninger, MD, PhD, FANA, FWSO (UMass Memorial Medical Center) Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
No disclosure on file